29 Jun , 2026 By : Debdeep Gupta
Dr Reddy's Laboratories shares extended their gaining streak to the sixth consecutive session on Monday, emerging among the top performers on the Nifty50 index.
The stock gained after the US drug regulator completed an inspection at the company's biologics facility in Bachupally, Hyderabad, and issued seven observations. The company said it would address the observations within the stipulated timeline.
Over the past seven trading sessions, the stock has risen more than 10 percent.
Around 4 million shares of the company changed hands, till 11:15 a.m. today, with a traded value of Rs 543.76 crore.
The trading volume was nearly double the average of 1.76 million shares traded over the previous seven sessions.
0 Comment